Park National Corp Merck & Co., Inc. Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Park National Corp holds 54,690 shares of MRK stock, worth $5.36 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

54,690

Previous 55,388 1.26%

Holding current value

$5.36 Million

Previous $6.86 Million 9.44%

% of portfolio

0.22%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$111.15 - $128.97 $77,582 - $90,021	-698 Reduced 1.26%	54,690 $6.21 Million
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $3.44 Million - $3.7 Million	-27,795 Reduced 33.41%	55,388 $6.86 Million
Q1 2024 Apr 01, 2024	SELL	$113.24 - $131.95 $905,240 - $1.05 Million	-7,994 Reduced 8.77%	83,183 $11 Million
Q4 2023 Jan 02, 2024	SELL	$100.18 - $109.02 $430,172 - $468,131	-4,294 Reduced 4.5%	91,177 $9.94 Million
Q3 2023 Oct 02, 2023	SELL	$102.95 - $114.33 $129,099 - $143,369	-1,254 Reduced 1.3%	95,471 $9.83 Million
Q2 2023 Jul 03, 2023	SELL	$108.61 - $118.38 $328,219 - $357,744	-3,022 Reduced 3.03%	96,725 $11.2 Million
Q1 2023 Apr 03, 2023	SELL	$102.94 - $114.86 $194,144 - $216,625	-1,886 Reduced 1.86%	99,747 $10.6 Million
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $86,565 - $110,988	-990 Reduced 0.96%	101,633 $11.3 Million
Q3 2022 Oct 03, 2022	BUY	$84.53 - $94.96 $33,304 - $37,414	394 Added 0.39%	102,623 $8.84 Million
Q2 2022 Jul 01, 2022	SELL	$83.49 - $94.64 $783,303 - $887,912	-9,382 Reduced 8.41%	102,229 $9.32 Million
Q1 2022 Apr 01, 2022	SELL	$73.51 - $82.4 $518,539 - $581,249	-7,054 Reduced 5.94%	111,611 $9.16 Million
Q4 2021 Jan 04, 2022	SELL	$72.28 - $90.54 $524,680 - $657,229	-7,259 Reduced 5.76%	118,665 $9.09 Million
Q3 2021 Oct 01, 2021	SELL	$71.68 - $78.83 $1.03 Million - $1.13 Million	-14,332 Reduced 10.22%	125,924 $9.46 Million
Q2 2021 Jul 01, 2021	SELL	$70.31 - $77.77 $1.5 Million - $1.66 Million	-21,380 Reduced 13.23%	140,256 $10.9 Million
Q1 2021 Apr 01, 2021	SELL	$68.86 - $81.11 $4.08 Million - $4.81 Million	-59,259 Reduced 26.83%	161,636 $12.5 Million
Q4 2020 Jan 04, 2021	SELL	$71.77 - $79.65 $736,144 - $816,970	-10,257 Reduced 4.44%	220,895 $18.1 Million
Q3 2020 Oct 01, 2020	SELL	$73.18 - $82.95 $1.76 Million - $1.99 Million	-24,001 Reduced 9.41%	231,152 $19.2 Million
Q2 2020 Jul 01, 2020	SELL	$70.42 - $80.13 $1.41 Million - $1.61 Million	-20,051 Reduced 7.29%	255,153 $19.7 Million
Q1 2020 Apr 01, 2020	SELL	$63.36 - $87.82 $935,256 - $1.3 Million	-14,761 Reduced 5.09%	275,204 $21.2 Million
Q4 2019 Jan 02, 2020	SELL	$77.58 - $87.54 $1.38 Million - $1.56 Million	-17,807 Reduced 5.79%	289,965 $26.4 Million
Q3 2019 Oct 01, 2019	SELL	$76.08 - $82.93 $983,562 - $1.07 Million	-12,928 Reduced 4.03%	307,772 $25.9 Million
Q2 2019 Jul 01, 2019	SELL	$69.84 - $81.59 $3.48 Million - $4.06 Million	-49,791 Reduced 13.44%	320,700 $26.9 Million
Q1 2019 Apr 01, 2019	SELL	$69.58 - $79.36 $3.02 Million - $3.45 Million	-43,469 Reduced 10.5%	370,491 $30.8 Million
Q4 2018 Jan 02, 2019	SELL	$65.24 - $75.71 $238,452 - $276,720	-3,655 Reduced 0.88%	413,960 $31.6 Million
Q3 2018 Oct 02, 2018	SELL	$57.69 - $67.84 $83,938 - $98,707	-1,455 Reduced 0.35%	417,615 $29.6 Million
Q2 2018 Jul 02, 2018	BUY	$50.83 - $59.72 $183,699 - $215,828	3,614 Added 0.87%	419,070 $25.4 Million
Q1 2018 Apr 02, 2018	BUY	$50.96 - $59.23 $239,868 - $278,795	4,707 Added 1.15%	415,456 $22.6 Million
Q4 2017 Jan 02, 2018	SELL	$51.62 - $61.64 $581,396 - $694,251	-11,263 Reduced 2.67%	410,749 $23.1 Million
Q3 2017 Oct 02, 2017	BUY	$58.67 - $63.13 $24.8 Million - $26.6 Million	422,012	422,012 $27 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Merck & Co., Inc. Transaction History